FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 320:138-142 January 19, 1989 Number 3 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

A deficiency of the protein dystrophin is known to be the cause of Duchenne's muscular dystrophy. To examine the expression of dystrophin in symptomatic female carriers of this X-linked recessive disorder, we performed immunohistochemical studies on muscle-biopsy specimens from three such carriers, using an antiserum raised against a synthetic peptide fragment of dystrophin. In all three carriers, most individual muscle fibers reacted either strongly or not at all to the antiserum for dystrophin; only 2 to 8 percent of fibers showed partial immunostaining. This mosaic staining pattern was present on both cross-sectional and longitudinal muscle specimens. Although the mosaic pattern was seen in all fiber types, more than 80 percent of type 2B and 2C fibers from two of the carriers did not react with the antiserum. Similar studies in nine normal subjects showed consistently strong staining of all muscle fibers. No muscle fibers from 31 patients with Duchenne's muscular dystrophy reacted with the antiserum. We conclude that symptomatic carriers of Duchenne's muscular dystrophy can be identified by a distinct mosaic pattern in the immunohistochemical staining of the surface membrane of skeletal-muscle specimens. This finding may have practical implications for genetic counseling, although it remains to be shown whether the same staining pattern will be found in muscle specimens from asymptomatic carriers of Duchenne's muscular dystrophy.

Source Information

National Institute of Neuroscience, Tokyo, Japan.

This article has been cited by other articles:

• Hoogerwaard, E. M., Ginjaar, I. B., Bakker, E., de Visser, M. (2005). Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy. Neurology 65: 1984-1986 [Abstract] [Full Text]  
• Yue, Y., Skimming, J. W., Liu, M., Strawn, T., Duan, D. (2004). Full-length dystrophin expression in half of the heart cells ameliorates {beta}-isoproterenol-induced cardiomyopathy in mdx mice. Hum Mol Genet 13: 1669-1675 [Abstract] [Full Text]  
• Carrel, L., Cottle, A. A., Goglin, K. C., Willard, H. F. (1999). From the Cover: A first-generation X-inactivation profile of the human X chromosome. Proc. Natl. Acad. Sci. USA 96: 14440-14444 [Abstract] [Full Text]  
• Carrel, L., Willard, H. F. (1999). Heterogeneous gene expression from the inactive X chromosome: An X-linked gene that escapes X inactivation in some human cell lines but is inactivated in others. Proc. Natl. Acad. Sci. USA 96: 7364-7369 [Abstract] [Full Text]  
• Hoffman, E. P., Wang, J. (1993). Duchenne-Becker Muscular Dystrophy and the Nondystrophic Myotonias: Paradigms for Loss of Function and Change of Function of Gene Products. Arch Neurol 50: 1227-1237 [Abstract]  
• Tachi, N., Wakai, S., Yutoh, Y., Chiba, S., Miura, J. (1990). Asymptomatic HyperCKemia: Detection of an Isolated Carrier of Duchenne Muscular Dystrophy. J Child Neurol 5: 351-353  
• Witkowski, J.A. (1989). Review Article: Dystrophin-Related Muscular Dystrophies. J Child Neurol 4: 251-271 [Abstract]